From Molecule to Disease
PIPs Project of the Leibniz Cooperative Excellence Launched.
What role do certain lipids, known as phosphoinositides (PIPs), play in obesity and other metabolic diseases? This is now being investigated by scientists from the Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP) in Berlin, the German Institute of Human Nutrition Potsdam-Rehbrücke (DIfE), and the Leibniz-Institut für Analytische Wissenschaften (ISAS) in a joint project.
The FMP, DIfE and ISAS have raised almost one million euros from the Leibniz Association as part of the “Leibniz Cooperative Excellence” program, in order to study the role of phosphoinositides in a healthy organism and in metabolic diseases such as type 2 diabetes in more detail. The project will focus on a key aspect: it is assumed that these phospholipids transmit vital, food-dependent signals to cells and organs, such as whether the body is full or hungry, or whether it should switch to anabolic (building up) or catabolic (breaking down) metabolism. “We believe that PIPs play a key role in communication between cells, but how these processes work is barely understood,” says project leader and FMP director Prof. Dr. Volker Haucke.
Impaired metabolism due to altered PIP signaling?
The starting point for the project were investigations into a genetic muscle development disorder. FMP researchers showed that due to a missing or malfunctioning lipid phosphatase, fats could not be incorporated into the metabolism of mitochondria — the cell’s powerhouses. This rare genetic disease leads to death in childhood. Meanwhile, DIfE had linked the same gene to obesity. The researchers now aim to examine whether a shared fundamental mechanism — possibly altered PIP signaling — underlies both extremes, and to test additional hypotheses. “We research from molecule to disease,” emphasizes Volker Haucke, “because we want to understand what changes in metabolism occur depending on food availability.”
New analytical methods to decode signaling pathways
While FMP focuses on the molecular and cellular level, DIfE will conduct preclinical studies using two mouse models. ISAS, in turn, is responsible for developing the missing PIP analysis methods. The researchers will first create mass spectrometry methods to analyze the frequency and identity of PIPs in cells and tissues, for instance. “So far, the lack of analytics has hindered a better understanding of PIP signaling pathways,” explains Prof. Dr. Sven Heiles, head of the Lipidomics research group at ISAS. Applying theirnew analytical techniques, the scientists aim to investigate the physiological role of changes in cellular PIP levels due to changes in nutrient supply in selected cell systems. The consortium will then use these findings to further study PIP metabolism in mouse models under normal and increased nutrient supply conditions.
“We are aware that we are dealing with very complex questions here,” says Prof. Dr. Annette Schürmann from DIfE. “But we hope that this project will help us understand molecular processes following fasting and food intake and, in the long term, assist many people with obesity.”
The PIPMet project “Phosphoinositide-mediated nutrient response in metabolic disease” has started in February this year and is expected to run until July 2027. Both early-career and experienced researchers are involved.
Episode on the topic in the Wirkstoffradio
More information about the project is available in the podcast with Prof. Dr. Volker Haucke and Bernd Rupp. www.wirkstoffradio.de, Episode: WSR078 Phosphoinositide bei Stoffwechselkrankheiten PIPMet – Interview mit Prof. Dr. Volker Haucke. The interview was conducted in German.
https://www.wirkstoffradio.de/2024/08/04/wsr078-phosphoinositide-bei-stoffwechse…
Wissenschaftliche Ansprechpartner:
Prof. Dr. Volker Haucke
Research Unit Molecular Pharmacology and Cell Biology
Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP)
haucke@fmp-berlin.de
Phone.: +49 30 94793 100
Weitere Informationen:
More information about the project is available in the podcast with Prof. Dr. Volker Haucke and Bernd Rupp. www.wirkstoffradio.de, Episode: WSR078 Phosphoinositide bei Stoffwechselkrankheiten PIPMet – Interview mit Prof. Dr. Volker Haucke. The interview was conducted in German.
https://www.wirkstoffradio.de/2024/08/04/wsr078-phosphoinositide-bei-stoffwechse…
Media Contact
All latest news from the category: Life Sciences and Chemistry
Articles and reports from the Life Sciences and chemistry area deal with applied and basic research into modern biology, chemistry and human medicine.
Valuable information can be found on a range of life sciences fields including bacteriology, biochemistry, bionics, bioinformatics, biophysics, biotechnology, genetics, geobotany, human biology, marine biology, microbiology, molecular biology, cellular biology, zoology, bioinorganic chemistry, microchemistry and environmental chemistry.
Newest articles
Breakthrough in magnetism that could transform quantum computing and superconductors
Researchers discover new magnetic and electronic properties in kagome magnet thin films. A discovery by Rice University physicists and collaborators is unlocking a new understanding of magnetism and electronic interactions…
NASA to launch innovative solar coronagraph to Space Station
NASA’s Coronal Diagnostic Experiment (CODEX) is ready to launch to the International Space Station to reveal new details about the solar wind including its origin and its evolution. Launching in…
Boosting efficiency in mining with AI and automation
“Doing instead of procrastinating”. This is the AI strategy presented by Prof. Constantin Haefner, Director of the Fraunhofer Institute for Laser Technology ILT, at the “AKL’24 – International Laser Technology…